Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis

Detalhes bibliográficos
Autor(a) principal: Vieira, A.
Data de Publicação: 2011
Outros Autores: Heidor, R., Cardozo, M. T., Scolastici, C., Purgatto, E., Shiga, T. M., Barbisan, L. F. [UNESP], Ong, T. P., Moreno, F. S.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1590/S0100-879X2011007500037
http://hdl.handle.net/11449/18485
Resumo: β-ionone (βI), a cyclic isoprenoid, and geraniol (GO), an acyclic monoterpene, represent a promising class of dietary chemopreventive agents against cancer, whose combination could result in synergistic anticarcinogenic effects. The chemopreventive activities of βI and GO were evaluated individually or in combination during colon carcinogenesis induced by dimethylhydrazine in 48 3-week-old male Wistar rats (12 per group) weighing 40-50 g. Animals were treated for 9 consecutive weeks with βI (16 mg/100 g body weight), GO (25 mg/100 g body weight), βI combined with GO or corn oil (control). Number of total aberrant crypt foci (ACF) and of ACF ≥4 crypts in the distal colon was significantly lower in the GO group (66 ± 13 and 9 ± 2, respectively) compared to control (102 ± 9 and 17 ± 3) and without differences in the βI (91 ± 11 and 14 ± 3) and βI+GO groups (96 ± 5 and 19 ± 2). Apoptosis level, identified by classical apoptosis morphological criteria, in the distal colon was significantly higher in the GO group (1.64 ± 0.06 apoptotic cells/mm²) compared to control (0.91 ± 0.07 apoptotic cells/mm²). The GO group presented a 0.7-fold reduction in Bcl-2 protein expression (Western blot) compared to control. Colonic mucosa concentrations of βI and GO (gas chromatography/mass spectrometry) were higher in the βI and GO groups, respectively, compared to the control and βI+GO groups. Therefore, GO, but not βI, represents a potential chemopreventive agent in colon carcinogenesis. Surprisingly, the combination of isoprenoids does not represent an efficient chemopreventive strategy.
id UNSP_dd11961e1a4b38b80ebbe04b25b5e809
oai_identifier_str oai:repositorio.unesp.br:11449/18485
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesisColonCarcinogenesisChemopreventionβ-iononeGeraniolIsoprenoidAcyclic monoterpeneβ-ionone (βI), a cyclic isoprenoid, and geraniol (GO), an acyclic monoterpene, represent a promising class of dietary chemopreventive agents against cancer, whose combination could result in synergistic anticarcinogenic effects. The chemopreventive activities of βI and GO were evaluated individually or in combination during colon carcinogenesis induced by dimethylhydrazine in 48 3-week-old male Wistar rats (12 per group) weighing 40-50 g. Animals were treated for 9 consecutive weeks with βI (16 mg/100 g body weight), GO (25 mg/100 g body weight), βI combined with GO or corn oil (control). Number of total aberrant crypt foci (ACF) and of ACF ≥4 crypts in the distal colon was significantly lower in the GO group (66 ± 13 and 9 ± 2, respectively) compared to control (102 ± 9 and 17 ± 3) and without differences in the βI (91 ± 11 and 14 ± 3) and βI+GO groups (96 ± 5 and 19 ± 2). Apoptosis level, identified by classical apoptosis morphological criteria, in the distal colon was significantly higher in the GO group (1.64 ± 0.06 apoptotic cells/mm²) compared to control (0.91 ± 0.07 apoptotic cells/mm²). The GO group presented a 0.7-fold reduction in Bcl-2 protein expression (Western blot) compared to control. Colonic mucosa concentrations of βI and GO (gas chromatography/mass spectrometry) were higher in the βI and GO groups, respectively, compared to the control and βI+GO groups. Therefore, GO, but not βI, represents a potential chemopreventive agent in colon carcinogenesis. Surprisingly, the combination of isoprenoids does not represent an efficient chemopreventive strategy.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Universidade de São Paulo Laboratório de Dieta, Nutrição e CâncerUniversidade de São Paulo Faculdade de Ciências Farmacêuticas Departamento de Alimentos e Nutrição ExperimentalUniversidade Estadual Paulista Instituto de Biociências Departamento de MorfologiaUniversidade Estadual Paulista Instituto de Biociências Departamento de MorfologiaAssociação Brasileira de Divulgação Científica (ABRADIC)Universidade de São Paulo (USP)Universidade Estadual Paulista (Unesp)Vieira, A.Heidor, R.Cardozo, M. T.Scolastici, C.Purgatto, E.Shiga, T. M.Barbisan, L. F. [UNESP]Ong, T. P.Moreno, F. S.2014-05-20T13:51:45Z2014-05-20T13:51:45Z2011-06-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article538-545application/pdfhttp://dx.doi.org/10.1590/S0100-879X2011007500037Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 44, n. 6, p. 538-545, 2011.0100-879Xhttp://hdl.handle.net/11449/1848510.1590/S0100-879X2011007500037S0100-879X2011000600007WOS:000291613800007S0100-879X2011000600007.pdf3278528112652257SciELOreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBrazilian Journal of Medical and Biological Research1.492info:eu-repo/semantics/openAccess2023-11-09T06:13:40Zoai:repositorio.unesp.br:11449/18485Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T17:15:17.367820Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis
title Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis
spellingShingle Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis
Vieira, A.
Colon
Carcinogenesis
Chemoprevention
β-ionone
Geraniol
Isoprenoid
Acyclic monoterpene
title_short Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis
title_full Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis
title_fullStr Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis
title_full_unstemmed Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis
title_sort Efficacy of geraniol but not of β-ionone or their combination for the chemoprevention of rat colon carcinogenesis
author Vieira, A.
author_facet Vieira, A.
Heidor, R.
Cardozo, M. T.
Scolastici, C.
Purgatto, E.
Shiga, T. M.
Barbisan, L. F. [UNESP]
Ong, T. P.
Moreno, F. S.
author_role author
author2 Heidor, R.
Cardozo, M. T.
Scolastici, C.
Purgatto, E.
Shiga, T. M.
Barbisan, L. F. [UNESP]
Ong, T. P.
Moreno, F. S.
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de São Paulo (USP)
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Vieira, A.
Heidor, R.
Cardozo, M. T.
Scolastici, C.
Purgatto, E.
Shiga, T. M.
Barbisan, L. F. [UNESP]
Ong, T. P.
Moreno, F. S.
dc.subject.por.fl_str_mv Colon
Carcinogenesis
Chemoprevention
β-ionone
Geraniol
Isoprenoid
Acyclic monoterpene
topic Colon
Carcinogenesis
Chemoprevention
β-ionone
Geraniol
Isoprenoid
Acyclic monoterpene
description β-ionone (βI), a cyclic isoprenoid, and geraniol (GO), an acyclic monoterpene, represent a promising class of dietary chemopreventive agents against cancer, whose combination could result in synergistic anticarcinogenic effects. The chemopreventive activities of βI and GO were evaluated individually or in combination during colon carcinogenesis induced by dimethylhydrazine in 48 3-week-old male Wistar rats (12 per group) weighing 40-50 g. Animals were treated for 9 consecutive weeks with βI (16 mg/100 g body weight), GO (25 mg/100 g body weight), βI combined with GO or corn oil (control). Number of total aberrant crypt foci (ACF) and of ACF ≥4 crypts in the distal colon was significantly lower in the GO group (66 ± 13 and 9 ± 2, respectively) compared to control (102 ± 9 and 17 ± 3) and without differences in the βI (91 ± 11 and 14 ± 3) and βI+GO groups (96 ± 5 and 19 ± 2). Apoptosis level, identified by classical apoptosis morphological criteria, in the distal colon was significantly higher in the GO group (1.64 ± 0.06 apoptotic cells/mm²) compared to control (0.91 ± 0.07 apoptotic cells/mm²). The GO group presented a 0.7-fold reduction in Bcl-2 protein expression (Western blot) compared to control. Colonic mucosa concentrations of βI and GO (gas chromatography/mass spectrometry) were higher in the βI and GO groups, respectively, compared to the control and βI+GO groups. Therefore, GO, but not βI, represents a potential chemopreventive agent in colon carcinogenesis. Surprisingly, the combination of isoprenoids does not represent an efficient chemopreventive strategy.
publishDate 2011
dc.date.none.fl_str_mv 2011-06-01
2014-05-20T13:51:45Z
2014-05-20T13:51:45Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0100-879X2011007500037
Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 44, n. 6, p. 538-545, 2011.
0100-879X
http://hdl.handle.net/11449/18485
10.1590/S0100-879X2011007500037
S0100-879X2011000600007
WOS:000291613800007
S0100-879X2011000600007.pdf
3278528112652257
url http://dx.doi.org/10.1590/S0100-879X2011007500037
http://hdl.handle.net/11449/18485
identifier_str_mv Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 44, n. 6, p. 538-545, 2011.
0100-879X
10.1590/S0100-879X2011007500037
S0100-879X2011000600007
WOS:000291613800007
S0100-879X2011000600007.pdf
3278528112652257
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Brazilian Journal of Medical and Biological Research
1.492
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 538-545
application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica (ABRADIC)
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica (ABRADIC)
dc.source.none.fl_str_mv SciELO
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128780769689600